Good morning. Happy Monday. Hope you had a good weekend.
The Asian/Pacific markets closed mostly down. Thailand did well, but Japan, China, Hong Kong, South Korea, Taiwan, Austria and the Philippines were weak. Europe, Africa and the Middle East are currently mixed. Turkey, Greece, Norway, Australia and Saudi Arabia are up; South Africa and Kenya are down. Futures in the States point towards a slight down open for the cash market.
—————
BLOG: CCI – Everything You Need to Know
—————
The dollar is down. Oil and copper are up. Gold and silver are up. Bonds are down.
Overnight Stock Movers from barchart.com…
Bank of America (BAC +0.35%) slid 1% in pre-market trading after it reported Q3 trading revenue of $3.10 billion, below consensus of $3.15 billion.
Rockwell Automation (ROK +1.28%) was downgraded to ‘Underperform’ from ‘Market Perform’ at Cowen with a price target of $150
Activision Blizzard (ATVI +5.51%) was upgraded to ‘Overweight’ from ‘Equal-Weight’ at Barclays with a price target of $86.
Parker-Hannifin (PH +1.03%) was downgraded to ‘Underperform’ from ‘Market Perform’ with a price target of $150.
Boston Properties (BXP +0.29%) was upgraded to ‘Buy’ from ‘Hold’ at Jefferies with a price target of $139.
PNC Financial Services Group (PNC -5.58%) was upgraded to ‘Outperform’ from ‘Market Perform’ at Bernstein with a price target of $145.
Ralph Lauren (RL +3.20%) was upgraded to ‘Overweight’ from ‘Neutral’ at JPMorgan Chase with a price target of $150.
Mallinckrodt PLC (MNK +3.78%) may open higher initially this morning after D.E. Shaw said after the close Friday that it raised its passive stake in the company to 5.1% from 0.13% on June 30.
Kala Pharmaceuticals (KALA +6.20%) rose nearly 2% in after-hours trading after Longitude Capital reported a 9.0% stake in the company.
Intellia Therapeutics (NTLA +3.33%) fell 1% in after-hours trading after it filed to offer up to $100 million of the company’s common stock in an underwritten public offering.
Progenics Pharmaceuticals (PGNX -0.54%) lost nearly 2% in after-hours trading after it entered into a “controlled equity offering” sales pact with Cantor Fitzgerald for the sale of up to $75 million of Progenics’ common stock.
AcelRx Pharmaceuticals (ACRX +6.78%) surged 17% in after-hours trading after advisers to the FDA approved the company’s Dsuvia painkiller, saying its benefits outweigh any safety risks.
Today’s Economic Calendar
8:30 Empire State Mfg Survey
8:30 Retail Sales
10:00 Business Inventories
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY